OR32. Efficacy and Safety of Therapeutic Versus Prophylactic Dose of Anticoagulation in Hospitalized Patients with Severe COVID-19 Pneumonia and Coagulopathy: An Open-Label, Randomized Controlled Trial

被引：0
|
作者：
Adrian, L. H. [1 ]
Hutomo, S. A. [1 ]
Negari, A. D. S. [1 ]
机构：
[1] Syarifah Ambami Rato Ebu Gen Hosp, Dept Cardiol & Vasc Med, East Java, Indonesia
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2021年 / 23卷 / SUPPL F期
关键词：
COVID-19; coagulopathy; therapeutic; anticoagulant; efficacy; safety;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial
    Ameri, Ali
    Asadi, Masoomeh Frouz
    Ziaei, Ava
    Vatankhah, Majid
    Safa, Omid
    Kamali, Manoochehr
    Fathalipour, Mohammad
    Mahmoodi, Masoumeh
    Hassanipour, Soheil
    INFLAMMOPHARMACOLOGY, 2023, 31 (01) : 265 - 274
  • [32] Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial
    Mohammad Bosaeed
    Ebrahim Mahmoud
    Ahmad Alharbi
    Hadeel Altayib
    Hawra Albayat
    Faisal Alharbi
    Khalid Ghalilah
    Abdulmajid Al Arfaj
    Jumana AlJishi
    Abdullatif Alarfaj
    Hajar Alqahtani
    Badriah M. Almutairi
    Manar Almaghaslah
    Nawaf M. Alyahya
    Abdullah Bawazir
    Saud AlEisa
    Abdulrahman Alsaedy
    Abderrezak Bouchama
    Malak Alharbi
    Majid AlShamrani
    Sameera Al Johani
    Majed Aljeraisy
    Mohammed Alzahrani
    Abdulhakeem O. Althaqafi
    Hassan Almarhabi
    Athari Alotaibi
    Nasser Alqahtani
    Yaseen M. Arabi
    Omar S. Aldibasi
    Ahmad Alaskar
    Infectious Diseases and Therapy, 2021, 10 : 2291 - 2307
  • [33] Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial
    Bosaeed, Mohammad
    Mahmoud, Ebrahim
    Alharbi, Ahmad
    Altayib, Hadeel
    Albayat, Hawra
    Alharbi, Faisal
    Ghalilah, Khalid
    Al Arfaj, Abdulmajid
    AlJishi, Jumana
    Alarfaj, Abdullatif
    Alqahtani, Hajar
    Almutairi, Badriah M.
    Almaghaslah, Manar
    Alyahya, Nawaf M.
    Bawazir, Abdullah
    AlEisa, Saud
    Alsaedy, Abdulrahman
    Bouchama, Abderrezak
    Alharbi, Malak
    AlShamrani, Majid
    Al Johani, Sameera
    Aljeraisy, Majed
    Alzahrani, Mohammed
    Althaqafi, Abdulhakeem O.
    Almarhabi, Hassan
    Alotaibi, Athari
    Alqahtani, Nasser
    Arabi, Yaseen M.
    Aldibasi, Omar S.
    Alaskar, Ahmad
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (04) : 2291 - 2307
  • [34] Safety and Efficacy of Selenium on Recovery of Hospitalized Patients with COVID-19: A Randomized Controlled Clinical Trial
    Shafiei, Elham
    Mahmoudvand, Golnaz
    Rouzbahani, Arian Karimi
    Nazari, Ali
    ARCHIVES OF CLINICAL INFECTIOUS DISEASES, 2023, 18 (04):
  • [35] Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial
    Sekhavati, Ehsan
    Jafari, Fatemeh
    SeyedAlinaghi, SeyedAhmad
    Jamalimoghadamsiahkali, Saeidreza
    Sadr, Sara
    Tabarestani, Mohammad
    Pirhayati, Mohammad
    Zendehdel, Abolfazl
    Manafi, Navid
    Hajiabdolbaghi, Mahboubeh
    Ahmadinejad, Zahra
    Kouchak, Hamid Emadi
    Jafari, Sirous
    Khalili, Hosein
    Salehi, Mohamadreza
    Seifi, Arash
    Golestan, Fereshteh Shahmari
    Ghiasvand, Fereshteh
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (04)
  • [36] Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial
    Koshak, Abdulrahman E.
    Koshak, Emad A.
    Mobeireek, Abdullah F.
    Badawi, Mazen A.
    Wali, Siraj O.
    Malibary, Husam M.
    Atwah, Ali F.
    Alhamdan, Meshari M.
    Almalki, Reem A.
    Madani, Tariq A.
    COMPLEMENTARY THERAPIES IN MEDICINE, 2021, 61
  • [37] Melatonin effects on sleep quality and outcomes of COVID-19 patients: An open-label, randomized, controlled trial
    Mousavi, Seyed Abbas
    Heydari, Keyvan
    Mehravaran, Hossein
    Saeedi, Majid
    Alizadeh-Navaei, Reza
    Hedayatizadeh-Omran, Akbar
    Shamshirian, Amir
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (01) : 263 - 271
  • [38] NASAFYTOL® supplementation in adults hospitalized with COVID-19 infection: results from an exploratory open-label randomized controlled trial
    Gerain, Jean
    Uebelhoer, Melanie
    Costes, Berenice
    Herman, Julie
    Pietri, Sandra
    Donneau, Anne-Francoise
    Monseur, Justine
    Henrotin, Yves
    FRONTIERS IN NUTRITION, 2023, 10
  • [39] The therapeutic efficacy of quercetin in combination with antiviral drugs in hospitalized COVID-19 patients: A randomized controlled trial
    Shohan, Mojtaba
    Nashibi, Roohangiz
    Mahmoudian-Sani, Mohammad-Reza
    Abolnezhadian, Farhad
    Ghafourian, Mehri
    Alavi, Seyed Mohammad
    Sharhani, Asaad
    Khodadadi, Ali
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 914
  • [40] Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial
    Ivan O. Rosas
    George Diaz
    Robert L. Gottlieb
    Suzana M. Lobo
    Philip Robinson
    Bradley D. Hunter
    Adilson W. Cavalcante
    J. Scott Overcash
    Nicola A. Hanania
    Alan Skarbnik
    Julia Garcia-Diaz
    Ivan Gordeev
    Jordi Carratalà
    Oliver Gordon
    Emily Graham
    Nicholas Lewin-Koh
    Larry Tsai
    Katie Tuckwell
    Huyen Cao
    Diana Brainard
    Julie K. Olsson
    Intensive Care Medicine, 2021, 47 : 1258 - 1270
12345